IGCL
Indogulf Cropsciences financials
- Market cap
- ₹460 Cr
- Sector
- Chemicals
- Calls analysed
- 5
Indogulf Cropsciences Limited Q1 FY27
What went well
- Gross margins improved significantly to 28% in Q1 FY27 from 22% in Q1 FY26, reflecting better cost and product mix.
- EBITDA margin expanded to 5.7% in Q1 FY27 from 5.2% in Q1 FY26, demonstrating operating model resilience.
- Capacity utilization increased to 70% during Q1 FY27 compared to 52% in FY26, providing a strong foundation for Kharif season.
What to watch
- Revenue from operations declined by 11% YoY to Rs. 168.5 crores in Q1 FY27 from Rs. 189.4 crores in Q1 FY26.
- PAT declined to Rs. 2.4 crores in Q1 FY27 from Rs. 3.9 crores in Q1 FY26.
What Indogulf Cropsciences Limited does
Indogulf Cropsciences manufactures and markets crop-protection products (insecticides, fungicides, herbicides, plant growth regulators), plant nutrients (straight fertilizers, soil health products) and biologicals (bio-fertilizers, bio-stimulants) for farmers across the crop life cycle. It runs four backward-integrated manufacturing facilities in Haryana and Jammu & Kashmir, covering both technical and formulation manufacturing. Products reach farmers through a large B2C distributor network, institutional (B2B) partners, and exports to overseas business partners across Asia, Africa, Latin America and the Middle East.
Segments
- Crop Protection
- Biologicals
- Plant Nutrients
- Others
- Manufacturing facilities
- 4 (Nathupur-I, Nathupur-II, Barwasni in Haryana; Samba in J&K)
- Installed manufacturing capacity
- ~42,564 MT/KL formulation (Nathupur-I 13,500 + Barwasni 20,064 + Samba 9,000) + 1,360 TPA technical (Nathupur-II)
- Capacity utilization
- 52% (FY26, up from 44% in FY23)
- Distributor network (B2C)
- 7,000+
- Export countries
- 34+
- Products portfolio
- 300+
Guidance record · Q1 FY27
what the last two calls moved 11 tracked 0 delivered 4 missed 7 open- FY26 Revenue Growth missed said Q1 FY26 Promised: 30% to 35% year-over-year growth annually Q1 FY27: Promise period ended. Final verdict is 'missed'.
- New Dry Flowable Plant Commissioning delayed said Q1 FY26 Promised: by this fiscal end (FY26) Q1 FY27: Management reports ongoing investments in the DF manufacturing facility, consistent with the previously delayed timeline of FY27-end.
All 11 tracked — every revision, and every one management stopped mentioning.
Open the guidance ledgerQuarterly results
Q1 FY27: revenue down 12.3%, net profit down 23.1% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 233 | 98 | 123 | 185 | 246 +6% | 109 +10% | 136 +10% | 162 −12% |
| EBITDA | 27 | 10 | 20 | 9 | 30 +11% | 11 +12% | 21 +2% | 9 +0% |
| Net profit | 17 | 4 | 10 | 3 | 19 +14% | 4 +11% | 12 +25% | 2 −23% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance −39.8% 1Y
1Y: ₹112.37 on 10 Sept 2025 → ₹67.61. High ₹112.37 (10 Sept 2025), low ₹53.58 (25 Mar 2026).
How the price took the results
close before → close after
- Q1 FY27
- +1.0%
- 18 Aug
- Q4 FY26
- −7.2%
- 29 May
- Q3 FY26
- −5.1%
- 12 Feb
- Q2 FY26
- −1.9%
- 13 Nov
The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.
Financials, as filed
Revenue grew 15.2% a year over 1 year, FY25 to FY26. Operating margin held at 10.5%.
| Year ending | FY25 | FY26 |
|---|---|---|
| Revenue | ₹586 Cr | ₹676 Cr |
| Operating profit | ₹63 Cr | ₹71 Cr |
| Operating margin | 10.8% | 10.5% |
| Interest | ₹14 Cr | ₹17 Cr |
| Depreciation | ₹11 Cr | ₹11 Cr |
| Net profit | ₹32 Cr | ₹39 Cr |
| Net margin | 5.4% | 5.7% |
| Cash from operations | ₹-12 Cr | ₹-41 Cr |
| Free cash flow | ₹-52 Cr | ₹-69 Cr |
| ROCE | 13.0% | 12.0% |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Equity capital | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹24 Cr | ₹63 Cr | ₹63 Cr |
| Reserves | ₹131 Cr | ₹157 Cr | ₹180 Cr | ₹209 Cr | ₹377 Cr | ₹396 Cr |
| Borrowings | ₹79 Cr | ₹102 Cr | ₹189 Cr | ₹155 Cr | ₹208 Cr | ₹177 Cr |
| Other liabilities | ₹178 Cr | ₹139 Cr | ₹121 Cr | ₹154 Cr | ₹218 Cr | ₹177 Cr |
| Total liabilities | ₹411 Cr | ₹421 Cr | ₹513 Cr | ₹541 Cr | ₹866 Cr | ₹813 Cr |
| Fixed assets | ₹51 Cr | ₹53 Cr | ₹65 Cr | ₹44 Cr | ₹48 Cr | ₹48 Cr |
| Capital work in progress | ₹6 Cr | ₹9 Cr | ₹9 Cr | ₹22 Cr | ₹67 Cr | ₹76 Cr |
| Investments | ₹3 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹15 Cr | ₹12 Cr |
| Other assets | ₹352 Cr | ₹359 Cr | ₹440 Cr | ₹474 Cr | ₹736 Cr | ₹678 Cr |
| Total assets | ₹411 Cr | ₹421 Cr | ₹513 Cr | ₹541 Cr | ₹866 Cr | ₹813 Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
Since Jun 2025, promoters trimmed −27.81 pp while the public added +23.28 pp. The shareholder count grew 84786% to 23,768.
- Promoters
- 69.0%
- FIIs
- 0.2%
- DIIs
- 4.3%
- Public
- 26.4%
Since Jun 2025
- Promoters −27.81 pp
- Public +23.28 pp
- DIIs +4.30 pp
How it drifted, 5 quarters
Over this window promoters fell from 96.9% to 69.0% — −27.8 pp.
Ownership split by quarter, oldest first. Jun '25: Promoters 96.9%, Public 3.1%.Sep '25: Promoters 69.0%, FIIs 0.4%, DIIs 6.2%, Public 24.3%.Dec '25: Promoters 69.0%, FIIs 0.2%, DIIs 4.4%, Public 26.4%.Mar '26: Promoters 69.0%, FIIs 0.2%, DIIs 4.4%, Public 26.4%.Jun '26: Promoters 69.0%, FIIs 0.2%, DIIs 4.3%, Public 26.4%.
Who is on the register
Named in the Jun 2026 filing
Every holder of Indogulf Cropsciences Limited above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Sanjay Aggarwal | 20.24% | unchanged |
| Arnav Aggarwal | 13.60% | unchanged |
| Anshu Aggarwal | 13.39% | unchanged |
| Om Parkash Aggarwal | 11.20% | unchanged |
| Abhiprakash Venture Trust | 5.47% | unchanged |
| Abakkus Diversified Alpha Fund AIF | 4.02% | unchanged |
| Viney Equity Market Llp | 2.33% | −0.24 pp |
| Sanshi Aggarwal | 1.58% | unchanged |
| Anamica Aggarwal | 1.58% | unchanged |
| Rachita Aggarwal | 1.58% | unchanged |
| Himanshi Lohia | 1.17% | unchanged |
| Sanjay Aggarwal - 2 | 0.40% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
All earnings calls (5)
Read the Q1 FY27 call →Learn to analyse Indogulf Cropsciences Limited
Guides on how to read this kind of business and the numbers that matter.